Steve Sanford, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 3900 Ben Hur Ave, Willoughby, OH 44094 Phone: 440-975-4185 Fax: 440-975-4195 |
News Archive
Critical Outcome Technologies Inc. announced more positive results today from animal experiments carried out at a prominent Canadian cancer research facility. This new series of experiments adds to the impressive data package for COTI-2, demonstrating efficacy both as a single agent and in combination with current first line therapies, as well as low toxicity in several different animal models of human cancers.
During the Forum of the African AIDS Vaccine Program (AAVP) in Kampala, Uganda, on Wednesday, Alan Bernstein, the director of the Global HIV Vaccine Enterprise, discussed ongoing efforts to launch an experimental HIV vaccine trial - similar to the recent trial in Thailand - in Africa, the Daily Monitor reports.
The results of a survey were published on the medRxiv* preprint server, the purpose of which was to assess the relative well-being of the population under Covid-19 restrictions – through 952 survey respondents from France, India, Italy, the UK, and the US.
New data from a Phase IIB clinical study of odanacatib, Merck & Co., Inc.'s oral, once-weekly investigational treatment for osteoporosis, showed that when stopping treatment after two years, the increases in lower back (lumbar spine) bone mineral density (BMD) were reversed over the next year, while BMD at the hip (femoral neck) remained above levels observed at the start of the study.
"Following criticism over a spate of patient deaths from adverse events during clinical trials, India has begun tightening up rules for clinical research and compensation as well as expanding its pool of medical experts," SciDev.Net reports.
› Verified 2 days ago